MAP3K5 and diabetes mellitus: It was reported that stress-activated ASK1 accelerates endothelial cell senescence in patients with diabetes [20] and that the inhibition of the ASK1-p38 MAPK pathway could be useful for preventing vascular ageing and for treating neurodegenerative and cardiac diseases [18, 21].